Charles Erlichman MD

Oncology•Rochester, MN

Gastrointestinal Cancer, Hematologic Oncology

Professor, Oncology, Mayo Medical School

Join to View Full Profile

200 1st St SwRochester, MN 55905
Phone+1 507-284-2511

Summary

Dr. Charles Erlichman is an oncologist in Rochester, MN. He received his medical degree from University of Toronto Faculty of Medicine and has been in practice 43 years. He specializes in gastrointestinal cancer and hematologic oncology and is experienced in clinical research, combined modality therapy, gastrointestinal oncology, peritoneal neoplasms, and cell survival.

Education & Training

University of Toronto Faculty of MedicineClass of 1974, MD

Certifications & Licensure

MN State Medical License 1994 - 2019

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 1995

Clinical Trials

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer Start of enrollment: 1999 Apr 01
Completed
Phase 1
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Start of enrollment: 1999 Aug 01
Completed
Phase 1
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Jan 01
Completed
Phase 1
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Aug 01
Completed
Phase 1
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary Start of enrollment: 2004 Feb 01
Completed
Phase 2
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Mar 01
Completed
Phase 2
Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas Start of enrollment: 2004 Nov 01
Terminated
Phase 1
CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 Oct 01
Completed
Phase 1
Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies Start of enrollment: 2004 Sep 01
Completed
Phase 1
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery Start of enrollment: 2008 Aug 01
Completed
Phase 1
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery Start of enrollment: 2009 Mar 31
ACTIVE_NOT_RECRUITING
PHASE1
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer Start of enrollment: 2007 Nov 01
Terminated
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Start of enrollment: 2009 Sep 08
Completed
Phase 2
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2012 Mar 05
Completed
Phase 1
Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors Start of enrollment: 2015 Feb 18
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R Antonescu
Cancer. 2024-03-01
1 citations
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg
Endocrine-Related Cancer. 2023-11-01
6 citations
Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine Tumors.
Mojun Zhu, Brian A Costello, Jun Yin, Adam M Pettinger, Jonathan R Strosberg
Pancreas. 2022-01-18

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Fellow
American Association for Cancer Research - AACR
Member